Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. health based
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Events
Downloads
Videos

Refine by
Date

  • Older

Health Based Articles & Analysis

155 news found

Advanced Bacterial Reverse Mutation Test (Ames) Service to Accelerate Medical Device Safety Assessment

Advanced Bacterial Reverse Mutation Test (Ames) Service to Accelerate Medical Device Safety Assessment

STEMart, a US-based provider of comprehensive services for all phases of medical device development, announced the expansion of its service offerings to include the Bacterial Reverse Mutation Test (Ames) service. ...

BySTEMart


SOPHiA Genetics Achieves ISO 27017 and ISO 27018 Certifications

SOPHiA Genetics Achieves ISO 27017 and ISO 27018 Certifications

“We are raising the bar for how cloud-based health data should be managed and protected,” said Daan van Well, Chief Legal and Regulatory Officer of SOPHiA GENETICS. ...

BySOPHiA Genetics


The association between farm-level antimicrobial usage and resistance of Staphylococcus spp., as the major genus isolated from aerosol samples, in Japanese piggeries

The association between farm-level antimicrobial usage and resistance of Staphylococcus spp., as the major genus isolated from aerosol samples, in Japanese piggeries

Bacteria are present in large numbers in livestock buildings, and can threaten animal and public health. Antimicrobial resistance (AMR) is a major concern worldwide, and national measures based on the “One Health” approach are being implemented in many countries. ...

ByBertin Technologies


CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program

CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program

Canaquest Medical Corp (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous system (CNS), today announced that it has been awarded the Best Global Medical Cannabinoid Development Company 2023, in its eighth annual Healthcare and Pharmaceutical ...

ByCanaQuest Medical Corp.


CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine

CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine

Neeka is led by a team of proven healthcare and clinical research innovators and is taking a disruptive approach to healthcare by encompassing a holistic approach to improving the quality of life for struggling and transition populations by using the proprietary Neeka peer support platform coupled with science based natural therapeutics. Dr. Amin Kassam, the CEO of Neeka, a true ...

ByCanaQuest Medical Corp.


Lifespin Announces Expansion of Laboratory Testing Capability

Lifespin Announces Expansion of Laboratory Testing Capability

” Lifespin is working to build new precision medicine tools based on quantitative metabolic profiles and proprietary algorithms to assist in the early detection of diseases and monitoring the efficacy of health treatments. ...

ByLifespin GmbH


Iterative Health Partners with Gastro Health to Accelerate Clinical Research in Gastroenterology Through Artificial Intelligence

Iterative Health Partners with Gastro Health to Accelerate Clinical Research in Gastroenterology Through Artificial Intelligence

To date, the company has raised $195M in funding and is rapidly growing in pursuit of its mission to use computer vision-based technology to reduce disparities in healthcare. Iterative Health has partnered with multiple clinical research sites and continues to expand its impact and reach through this relationship with Gastro Health. ...

ByIterative Health, Inc.


THINK Surgical Announces Collaboration with Definition Health

THINK Surgical Announces Collaboration with Definition Health

(FREMONT, CA) December 5, 2022 – THINK Surgical, a technology innovator developing orthopedic surgical robots, today announced a collaboration with UK based digital health company, Definition Health. The companies will jointly develop a seamless, web-based, connected care solution to enhance the surgical planning ...

ByThink Surgical Inc.


Synbiotic Health Announces the Expansion of their R&D and Commercial Capabilities with the Acquisition of a New Facility in Madison, Wisconsin

Synbiotic Health Announces the Expansion of their R&D and Commercial Capabilities with the Acquisition of a New Facility in Madison, Wisconsin

Based on over 10 years of research, Synbiotic Health will develop and commercialize Ecologically Advanced Probiotics® as well as rationally designed Synergistic Synbiotics®. The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other ...

BySynbiotic Health


Longenesis and Dante Genomics Partner to Make Personalised Medicine More Accessible Across Europe

Longenesis and Dante Genomics Partner to Make Personalised Medicine More Accessible Across Europe

“Our new partnership with Dante Genomics will make it easier for women to access exciting new DNA testing opportunities that will provide greater health insights. Everyone deserves to have individualised understanding of their health DNA testing affords. ...

ByLongenesis


Oxford Brain Diagnostics’ grey matter quality measure selected as secondary outcome for Alzheimer’s Phase 2 clinical trial

Oxford Brain Diagnostics’ grey matter quality measure selected as secondary outcome for Alzheimer’s Phase 2 clinical trial

” Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford ...

ByOxford Brain Diagnostics Ltd.


High-Standard Fermented Raw Materials that Satisfy the Quality Attributes of Healthcare Products

High-Standard Fermented Raw Materials that Satisfy the Quality Attributes of Healthcare Products

BOC Sciences is a trustworthy supplier that offers high-quality nutrient products and innovative solutions to global customers in the field of nutrition and health products through sustainable microbial manufacturing based on its advanced (bio)technologies, integrated and optimized industrial strain, as well as precise and efficient fermentation, separation, and ...

ByBOC Sciences


Kephera Diagnostics receives $417,074 grant award from the Massachusetts Life Sciences Center to accelerate development of its rapid COVID-19 Antigen Test

Kephera Diagnostics receives $417,074 grant award from the Massachusetts Life Sciences Center to accelerate development of its rapid COVID-19 Antigen Test

Among the four initial A.C.T.S. awardees are two companies: Framingham-based Kephera Diagnostics and Wellesley-based Virex Health; and two research hospitals: Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital. ...

ByKephera Diagnostics, LLC


Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)

Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)

Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life threatening critical care conditions and community based health emergencies, announced today that the U.S. Food and Drug Administration (FDA) has granted its lead compound, ENA-001, Orphan Drug Designation for the treatment of Apnea of ...

ByEnalare Therapeutics Inc.


Lifespin Launches Commercial Access to its Metabolic Profiler Software and Database for Pharma and Biobank Services

Lifespin Launches Commercial Access to its Metabolic Profiler Software and Database for Pharma and Biobank Services

” Lifespin (www.lifespin.health) is a deep data company that maps human health based on snapshots of metabolic states. Lifespin has standardized the baseline for human health to detect distinct deviations in the human metabolism caused by diseases. ...

ByLifespin GmbH


Molecular Health receives IVDR certification for MH Guide

Molecular Health receives IVDR certification for MH Guide

Molecular Health, an international biotech IT company based in Heidelberg, Germany, has received European Union certification for its MH Guide clinical decision support software (SaaS) under the new In Vitro Diagnostics Regulation (EU) 2017/746 (IVDR). ...

ByMolecular Health GmbH


Neurolief Announces Exclusive Licensing Agreement with NeuroFront for Development and Commercialization of Relivion in Greater China and South Korea

Neurolief Announces Exclusive Licensing Agreement with NeuroFront for Development and Commercialization of Relivion in Greater China and South Korea

Relivion has received both FDA clearance and CE mark for the treatment of migraine. The FDA marketing clearance is based on the results of a multi-center, prospective, randomized, double-blind, placebo-controlled clinical study. ...

ByNeurolief Ltd.


Kerendia (finerenone) approved in China for the treatment of adults with chronic kidney disease associated with type 2 diabetes

Kerendia (finerenone) approved in China for the treatment of adults with chronic kidney disease associated with type 2 diabetes

In Japan, Kerendia obtained approval by the Japanese Ministry of Health, Labour, and Welfare (MHLW) based on the results of both pivotal Phase III studies with finerenone in CKD and T2D in March 2022. Based on the results of the FIDELIO-DKD Phase III study, Kerendia was granted marketing authorization in the European Union in February 2022 and ...

ByBayer AG


ANGANY Gaining Momentum for Plant-Based Immunotherapy Platform

ANGANY Gaining Momentum for Plant-Based Immunotherapy Platform

Since then, ANGANY’s platform has attracted significant attention from major players in the Pharma and Animal Health markets. Based on this interest and following a successful Series A round of $ 15 million backed exclusively by private investors, ANGANY is currently preparing a Series B investment round of $ 35 million to finance upcoming clinical ...

ByAngany Inc.


VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders

VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders

The Total Brain platform helps more than one million individuals improve overall mental health and brain performance using several semi-quantitative functional methods. ...

ByVeriSIM Life

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT